tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Vamil Divan, 193 are a BUY (66.78%), 89 are a HOLD (30.8%), 7 are a SELL (2.42%).
Analyst Vamil Divan, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 63.44% that have a potential upside of 28.04% achieved within 224 days.
Vamil Divan’s has documented 611 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TVTX, Travere Therapeutics at 09-Sep-2024.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $276 was fulfilled within 3 days with a profit of $47.55 (20.81%) receiving and performance score of 69.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$209
$14.79 (7.62%)
$190
25 days ago
40/41 (97.56%)
$11.45 (5.80%)
477
Buy
$218
$23.79 (12.25%)
$196
1 months 5 days ago
12/13 (92.31%)
$27.82 (14.63%)
488
Buy
$200
$5.79 (2.98%)
$200
1 months 12 days ago
0/5 (0%)
$15.64 (8.48%)
Buy
$205
$10.79 (5.56%)
$180
1 months 22 days ago
4/6 (66.67%)
$19.84 (10.72%)
498
Buy
$210
$15.79 (8.13%)
$195
1 months 22 days ago
10/11 (90.91%)
$24.84 (13.42%)
426
Which stock is Vamil Divan is most bullish on?
Which stock is Vamil Divan is most reserved on?
What Year was the first public recommendation made by Vamil Divan?
